FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: novartis

Sort
E.g., 2013-06-19
E.g., 2013-06-19
Enter a comma separated list of user names.

GenVec, Inc. (NASDAQ: GNVC)

GNVC previously reported that it has extended its research collaboration and license agreement with Novartis. Novartis, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide.

GNVC, GenVec, Inc.

** GNVC reported that it has extended its Research Collaboration and License Agreement with Novartis.

Under the extension, Novartis will fund research at GNVC through January 2013 to support its hearing loss and balance disorders program.

Naugatuck Valley Financial Corp. (Nasdaq:NVSL) the parent company of Naugatuck Valley Savings and Loan (the "Bank"), announced net income of $254,000 for the quarter ended December 31, 2010, compared to net income of $684,000 for the quarter ended December 31, 2009, a decrease of $430,000 or 62.9%.

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii.

Pages

ADVERTISE WITH US